MDD stands for major depressive disorder, a clinical condition that goes well beyond ordinary sadness or a rough patch. It affects roughly 5.7% of adults worldwide and is defined by persistent changes in mood, energy, thinking, and physical functioning that last at least two weeks. Unlike temporary low moods that lift on their own, MDD disrupts daily life and, without treatment, episodes typically last six to twelve months.
How MDD Differs From Normal Sadness
Everyone feels sad, discouraged, or emotionally drained at times. Those feelings are usually tied to a specific event and fade within days. MDD is different in both intensity and duration. To meet the clinical threshold, a person must experience five or more defined symptoms nearly every day, for most of the day, over at least two consecutive weeks. At least one of those symptoms must be either a persistently depressed mood or a noticeable loss of interest or pleasure in almost all activities.
The remaining symptoms that count toward a diagnosis include significant unintentional weight change (more than 5% of body weight in a month) or a clear shift in appetite, sleep disturbances such as insomnia or oversleeping, observable physical restlessness or slowing down, persistent fatigue or low energy, feelings of worthlessness or excessive guilt, difficulty thinking or concentrating, and recurrent thoughts of death or suicide. These symptoms must represent a clear change from how the person functioned before and can’t be better explained by substance use or another medical condition.
What MDD Feels Like in the Body
Depression is often thought of as a purely emotional experience, but MDD has a strong physical dimension. In studies of people during active depressive episodes, the two most commonly reported symptoms were both physical: 73% described persistent tiredness, low energy, or listlessness, and 63% reported broken or reduced sleep. Disrupted appetite and digestion are also extremely common.
Beyond those core complaints, MDD can produce a wide range of bodily changes. Some people experience heart palpitations, shortness of breath, nausea, dizziness, excessive sweating, or sensations of coldness. Hair loss, decreased skin elasticity, loss of libido, and menstrual irregularities can all occur. These aren’t separate problems. They stem from the same disruption in brain signaling that drives the emotional symptoms, which is one reason MDD so often gets misidentified as a purely physical illness before the correct diagnosis is made.
What Happens in the Brain
Three brain regions play central roles in MDD: the prefrontal cortex (involved in decision-making and emotional regulation), the amygdala (which processes fear and emotional reactions), and the hippocampus (critical for memory and mood regulation). In people with MDD, the communication between these areas is disrupted.
The chemical messengers most closely linked to depression are serotonin, norepinephrine, and dopamine. Postmortem and biochemical studies show altered concentrations of these chemicals in the brain regions that regulate mood and motivation. The problem isn’t simply “too little serotonin,” as the old explanation suggested. It can involve reduced release of these messengers, faulty signaling at the receptors that receive them, or impaired processing of the signal inside the cell. For example, certain serotonin receptors in the amygdala, when overactive, can trigger anxiety, insomnia, and panic, while the same type of receptor dysfunction in the prefrontal cortex has been observed in people who died by suicide.
Risk Factors and Genetics
MDD runs in families, but it isn’t purely genetic. Twin studies estimate heritability at around 37%, and broader family-based studies place it between 28% and 44%. That means genetics account for roughly a third of the risk, with the remaining two-thirds coming from life circumstances, environment, and individual biology.
Well-established risk factors include a family history of depression or other psychiatric conditions, early-life trauma or abuse, chronic stress, social isolation, and certain medical illnesses. Women are affected at higher rates than men (6.9% versus 4.6% globally), though whether this reflects biological differences, differences in how symptoms are reported, or both remains an active question. Adults over 70 also face elevated risk, with a prevalence of about 5.9%.
How MDD Is Distinguished From Bipolar Disorder
This distinction matters because the treatments are different, and getting it wrong can make symptoms worse. The depressive episodes in bipolar disorder can look nearly identical to MDD. However, several patterns help clinicians tell them apart.
Bipolar depression is more likely to include “atypical” features: increased appetite, oversleeping, heavy feelings in the limbs, and mood that temporarily lifts in response to positive events. People with bipolar disorder also tend to show subsyndromal manic symptoms even during depressive episodes, things like pressured speech, racing thoughts, bursts of unusual energy, or inappropriate laughter. A family history of mania or bipolar disorder is one of the strongest differentiators. Bipolar depression also carries higher rates of co-occurring conditions like substance abuse, obsessive-compulsive disorder, and borderline personality disorder, along with higher rates of suicidality compared to unipolar MDD.
Treatment: Medication and Therapy
First-line medications for MDD are selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Other options include serotonin modulators and atypical antidepressants like bupropion and mirtazapine. These medications work by adjusting the availability of chemical messengers in the brain. Most take several weeks to produce noticeable effects, and finding the right medication often involves some trial and adjustment.
Psychotherapy is effective on its own for mild to moderate MDD and is often combined with medication for more severe cases. Cognitive behavioral therapy, which focuses on identifying and reshaping negative thought patterns, is the most widely studied approach. Interpersonal therapy, which targets relationship difficulties and life transitions that fuel depression, has also demonstrated clear benefits. In one randomized trial, 61% of people receiving interpersonal therapy showed at least a 50% improvement in symptoms after 12 months. Psychoeducational group therapy produced even higher response rates in the same study, with 76% showing that level of improvement.
For many people, 10 to 15 therapy sessions produce significant symptom relief. That said, the timeline varies with severity. More entrenched or recurrent depression generally requires longer treatment.
Long-Term Outlook
MDD is highly treatable, but it is also often recurrent. A single untreated episode lasts six to twelve months on average before resolving on its own, but the experience during that time can be devastating, affecting work, relationships, physical health, and safety. Treatment shortens episodes and reduces their severity. Perhaps more importantly, ongoing treatment (whether medication, therapy, or both) substantially lowers the risk of future episodes.
Roughly half of people who experience one major depressive episode will have at least one more during their lifetime. After two episodes, the probability of a third rises sharply. This is why clinicians often recommend continuing treatment for months or even years after symptoms improve, particularly for people with a history of recurrence or severe episodes. The goal shifts from acute recovery to prevention, keeping the next episode from taking hold.